Tirzepatide (30mg)

Tirzepatide acts on both the GIP and GLP-1 receptors, and is extensively referenced in incretin and metabolic research literature. This 30mg vial provides a higher-concentration option for researchers running extended or higher-throughput protocols.

Supplied as a sterile lyophilised powder intended for reconstitution with bacteriostatic water, for laboratory use only.

For laboratory research use only. Not for human or animal use. Not intended to diagnose, treat, cure, or prevent any disease.